Inhibitory activities of antioxidant flavonoids from tamarix gallica on amyloid aggregation related to Alzheimer's and type 2 diabetes diseases

Biological and Pharmaceutical Bulletin

Volumn 40, Issue 2, 2017, Pages 238-241

  Hmidene, Asma Ben ^a   Hanaki, Mizuho ^b   Murakami, Kazuma ^b   Irie, Kazuhiro ^b   Isoda, Hiroko ^a   Shigemori, Hideyuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Amyloid aggregation; Glucuronosylated flavonoid; Tamarix gallica; Type 2 diabetes

Indexed keywords

AGLYCONE; AMYLIN; AMYLOID; CARBOXYL GROUP; CATECHOL DERIVATIVE; FLAVONOID; GLUCURONIDE; HYDROXYL GROUP; KAEMPFEROL; KAEMPFEROL 3 O BETA D GLUCURONIDE; KAEMPFEROL 3 O BETA D GLUCURONIDE METHYL ESTHER; NARINGENIN; QUERCETIN; QUERCETIN 3 O BETA D GLUCURONIDE METHYL ESTHER; QUERCETIN 3 O BETA GLUCURONIDE; RHAMNAZIN; RHAMNETIN; TAMARIXETIN; UNCLASSIFIED DRUG; ANTIOXIDANT; PLANT EXTRACT;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; DRUG INHIBITION; ENZYME INHIBITION; HALOPHYTE; IC50; MEDICINAL PLANT; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN AGGREGATION; STRUCTURE ACTIVITY RELATION; TAMARIX GALLICA; ANTAGONISTS AND INHIBITORS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; PLANT STRUCTURES; PROTEINOSIS; TAMARICACEAE;

ALZHEIMER DISEASE; AMYLOID; ANTIOXIDANTS; DIABETES MELLITUS, TYPE 2; FLAVONOIDS; HUMANS; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; PROTEIN AGGREGATION, PATHOLOGICAL; TAMARICACEAE;

EID: 85011252564     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b16-00801     Document Type: Article

References (25)

1. Barbagalio M, Dominguez L. Type 2 diabetes mellitus and Alzheimer's diseases. World J. Diabetes, 5, 889-893 (2014).
2. Blázquez E, Velazquez E, Hurtado-Carneiro V, Ruiz-Albusac JM. Insulin in the brain: Its pathophysiological implications for states related with central insulin resistance, Type 2 diabetes and Alzheimer's disease. Front Endocrinol 5, 161 (2014).
3. Takeda S, Sato N, Rakugi FL Morishita R, Molecular mechanisms linking diabetes mellitus and Alzheimer's disease: beta-amyloid peptide, insulin signaling, and neuronal function. MoL Biosyst., 7, 1822-1827 (2011).
4. Zhao WQ, Townsend M. Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease. Biochim. Biophys. Acta, 1792, 482-496 (2009).
5. Haass C, Koo EH, Mellon A, Hung AY, Selkoe DI Targeting of cell-surface bet a-amyloid precursor protein to lyso somes: alternative processing into amyloid-bearing fragments. Nature, 357, 500-503 (1992).
6. Cooper GJ, Willis AC, Clark A, Himer RC, Sim KB, Reid KB. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc. Nat L Acad. Sci. U.S.A., 84, 8628-8632 (1987).
7. Janson J, Laedtke T, Parisi JE, O'Brien P, Petersen RC, Butler PC. Increased risk of type 2 diabetes in Alzheimer's disease. Diabetes, S3, 474-481 (2004).
8. Toyama BH, Weissman JS. Amyloid structure: Conformational diversity and consequences: Annu. Rev. Blochem, 80, 557 (2011).
9. Porat Y, Kolusheva S, Jelinek R. Gazit E. The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies. Biochemistry, 42, 10971-10977 (2003).
10. Green JDf Goldsbury C, Kistler J, Cooper G J. Aebi U. Human amy-lin oligomer growth and fibril elongation define two distinct phases in amyloid formation. J. Biol. Chem., 279, 12206-12212 (2004).
11. Kayed R, Head E, Thompson JL, Mcintire TM, Milton SC, Cotman CW, Glabe CG. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science, 300, 486-489 (2003).
12. Sato M, Murakami K, Uno M, Nakagawa Y, Katayama S, Akagi K, Masuda Y, Takegoshi K, Iric K. Si te-specific inhibitory mechanism for amyloid ß42 aggregation by catechol-type flavonoids targeting the Lys residues. J. Biol. Chem., 288, 23212-23224 (2013).
13. Sato M, Murakami K, Uno M, Ikubo H, Nakagawa Y, Katayama S, Akagi K, Irie K. Structure activity relationship for (+)-taxifolin isolated from Silymarin as an inhibitor of amyloid ß aggregation. Biosci Biotechnol Biochem. 77, 1100-1103 (2013).
14. Miyamae Y, Han J, Sasaki K, Terakawa M, Isoda IL Shigemori IL 3, 4, 5-Tri-O-caffeoylquinic acid inhibits amyloid ß-mediated cellular toxicity on SII-SY5Y cells through the upregulation of P GAMI and G3PDH. Cytotechnoiogy 63, 191-200 (2011).
15. Miyamae Y, Kurisu M, Murakami K, Han J, Isoda IL Irie K, Shigemori H. Protective effects of caffeoylquinic acids on the aggregation and neurotoxicity of the 42-re si due amyloid ß-protein. Bioorg. Med Chem., 20, 5844-5849 (2012).
16. Kurisu M, Miyamae Y, Murakami K, Han J, Isoda H, Irie K, Shigemori II. Inhibition of amyloid ß aggregation by acteoside, a phenyl -ethanoid glycoside. Biosci Biotechnol Biochem, 77, 1329-1332 (2013).
17. Tabassum N, Chatturvedi S, Agrawal SS. Effect of Tamarix gallica leaves on experimental liver cell injury, J K Practitioner, 13, 43-44 (2016).
18. Ksouri R, Falleh H, Megdiche W, Trabeisi N, Mhamdi B, Chaieb K, Bakrouf A, Magné C, Abdelly C. Antioxidant and antimicrobial activities of the edible medicinal halophyte Tamarix gallica. L. and related polyphenols constituents. Food Chem. Toxicol, 47, 2083-2091 (2009).
19. Mayuresh R, Andrzej R Patrycja LK Wojciech Z, Rafal R Herbal medicine for treatment and prevention of liver diseases. J. Preclinical Clin, Res.y 8, 55-60 (2014).
20. Murakami K, Irie K, Ohigashi IL Hara IL Nagao M, Shimizu T, Shira saw a T. Formation and stabilization model of the 42-mer Abeta radical: implications for the long-lasting oxidative stress in Alzheimer's disease. J. Am, Chem. Soc, 127, 15168-15174 (2005).
21. Saewan N, Koysomboom S, ChantraprommaK. An ti-tyrosinase and ant i-cane er activities of flavonoids from Blumea balsamiera DC. J. Med, Plants Res., 18, 1018-1025 (2011).
22. Paya M, Matiez S, Viliar A. Flavonoid constituents of Rhamnus lycioides. Z. Naturforsch., 41c, 976-978 (1986).
23. Naw war MAM, S ou lem an AMA, Buddrus J, Linscheid M. Flavonoids of the flowers of Tamarix nilotica. Phyiochemisiry, 23, 2347-2349 (1984).
24. Maltese F, Erkelens C, van der Kooy F, Choi YH, Ver poor te R. Identification of natural epimeric flavanone alveo si des bv NMR spectroscopy. Food Chem., 116, 575-579 (2009).
25. Park J, Ryu X Jin LH, Bahn JH, Kim JA, Yoon CS, Kim DW, Han KH, Elim WS, Kwon HY, Kang TC, Won MH, Kartg JH, Cho SW, Choi SY. 9-Polylysine protein transduction domain: Enhanced penetration efficiency of superoxide dismutase into mammalian cells and skin. Mol. Ceils, 13, 202-208 (2002).